News | LSHTM

Close

LSHTM

Found 0 results for your search. Showing 0 to 0.

No results could be found for your search.

Close

News

“Salmonella is a bacterial infection that can cause diarrhoeal disease, and especially in the vulnerable can lead to more severe symptoms." - Kathleen O'Reilly, Associate Professor at LSHTM

Rapid reaction: UK declares national outbreak of Salmonella Enteritidis

Tuesday 18 August 2026

“Using a shared modelling framework fitted to data across multiple countries can provide new insights into One Health intervention impacts but this is approach is currently limited by cross-sectoral comparable data on antibiotic use, resistance prevalence and length of AMR persistence in different settings such as the environment" - Gwen Knight, Professor at LSHTM

Natural environment key driver for increasing antibiotic resistance

Monday 10 August 2026

Quote from Katherine Horton: "In an era of reduced global health funding, our work can help decision-makers understand which TB interventions are likely to have the greatest impact."

New study shows anti-TB interventions need to impact whole communities

Tuesday 21 July 2026

Quote from Van Zandvoort: “Maternal vaccination and long-acting monoclonal antibodies can help protect children and prevent a substantial burden from respiratory syncytial virus.”

Children less than a year old most impacted by respiratory syncytial virus

Tuesday 2 June 2026

Quote from Andy Clark: “Our updated estimates show that many children in LMICs continue to receive vaccines much later than the recommended target age.”

Vaccines delayed for many children in nearly 100 countries

Monday 1 June 2026

Quote from Matthew Saunders: “Undernutrition is a critical driver of TB, which needs more attention in our efforts to end the TB epidemic.”

Ending undernutrition could stop nearly a quarter of TB cases

Tuesday 12 May 2026

Alvaro Schwalb: “Our study shows a sizeable population - over 134 million people worldwide - are at high risk of progression to tuberculosis disease.”

Expert comment: 134 million people living with recent Mycobacterium tuberculosis infection

Monday 11 May 2026

“Antibiotic prescriptions for typhoid fever should be informed by up-to-date, evidence-based resistance patterns. In situations where access to newer antibiotics is limited, older ones can still work if tests show the bacteria are sensitive. Systematic research and continuous surveillance of antibiotic resistance patterns are critical for effective typhoid control.” - Dr Vijayalaxmi Mogasale, Joint PhD Candidate, LSHTM-Nagasaki University

New study shows shifting typhoid resistance in India

Tuesday 28 April 2026

Quote from Rein Houben: “If we are serious about eliminating tuberculosis, we need to think about the full policy cascade: from funding to post-TB.”

Gaps within care for people living with TB

Thursday 2 April 2026

“Typhoid fever and its associated antibiotic resistance impose a considerable financial burden on the nation and on affected Indian households. For many, out-of-pocket costs for typhoid treatment are so high that they limit their ability to meet basic livelihood needs. Implementing vaccination programmes, responsible antibiotic use, and expanding social health insurance coverage can mitigate the economic impact of this disease at the national level.” Dr Vijayalaxmi Mogasale, Joint PhD Candidate, LSHTM-Naga

Typhoid fever costs billions for India’s economy and people

Tuesday 24 March 2026

Quote from Rebecca Clark: "Sudden funding cuts to TB services could threaten progress made towards ending TB, putting the poorest households under the most strain."

Billions of dollars damage from cuts to TB public health initiatives

Monday 9 March 2026

“For the first time, governments and the public can see how serious dengue is in different parts of the world.” Oliver Brady, Professor of Spatial Epidemiology, LSHTM

First global "early warning system" for dengue launches

Wednesday 4 March 2026